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Self-assembled multivalent (SAMul) ligands based on palmitic acid 
functionalised with cationic L/D-lysine  bind polyanionic heparin or 
DNA with no chiral preference.  Inserting a glycine spacer unit 
switches on chiral discrimination ʹ a rare example of controlled 
chiral recognition at a SAMul nanoscale interface. 
Molecular recognition at self-assembled surfaces is a key 
strategy used by biological systems to organise ligands over 
nanometre length scales, enabling adhesion to biomolecular 
targets.
1
  There is increasing interest in synthetic 
supramolecular systems which bind nanoscale biological 
targets,
2
 with multivalent binding being of particular use.
3
  
Self-assembly is a powerful strategy to organise such 
interactions.
4
  We have been developing self-assembled 
multivalent (SAMul) systems to bind polyanions such as DNA
5
 
and heparin,
6 
which have potential clinical relevance in gene 
therapy,
7
 and blood coagulation control,
8
 respectively.
 
 More 
broadly, it is worth noting that there are many polyanions in 
biological systems  ? including cell membranes, microfilaments 
and tubules.  Biology can control these polyanions with precise 
selectivity  ? understanding and intervening in this remains a 
real challenge.
9
  Self-assembled polycations are widely used to 
bind polyanions.
10
  Selectivity at such binding interfaces is 
primarily considered to be based on charge density;
11
 other 
factors are known to modulate selectivity, but the number of 
experimental examples is limited.
12
  We have therefore been 
interested in exploring the subtleties of polyanion recognition.  
We recently studied ligand modification in SAMul systems and 
found different polyanions exhibited different ligand 
preferences.
13
  We have also studied chiral systems, and found 
ligand chirality could enable enantioselective binding.
14
  Chiral 
micelles are known to separate enantiomers in capillary 
electrophoresis, with the low-molecular-weight analyte 
partitioning into the micelle, close to the surfactant chiral 
centre,
15
 but this is somewhat different to our report of chiral 
multivalent binding across the self-assembled surface.
14
  
However, the molecular structures in our previous report were 
relatively complex, and we therefore wanted to simplify our 
molecular design to probe the impact of simple structural 
modifications on chiral ligand display.
 
Figure 1.  Compounds investigated in this paper. and schematic of self-
assembled multivalent (SAMul) binding of polyanions. 
 In our new minimal design, Boc-protected L- or D-Lysine 
was coupled with 1-hexadecylamine using TBTU and Et3N in 
DCM, with the desired compounds C16-L-Lys and C16-D-Lys 
being obtained after removal of the protecting groups using 
HCl gas in methanol.  Similarly, the glycine-spaced compounds 
were synthesised using solution-phase TBTU-mediated peptide 
coupling and a Boc-protecting group strategy (see ESI).  The 
syntheses worked in good yields, with circular dichroism (CD) 
spectroscopy being used to confirm enantiomeric 
relationships; each pair of compounds exhibited mirror-image 
spectra (Table 1 and ESI).  The CD spectra of the compounds 
with and without a glycine spacer were different, reflecting the 
presence of the additional UV-chromophoric peptide bond.   
 We probed the critical aggregation concentrations (CACs) 
using a Nile Red assay in PBS buffer.
16
  The CACs of C16-L-Lys 
and C16-D-Lys were 33 ± 3 ʅD ĂŶĚ 29 ± 4 ʅD respectively, 
while those of C16-Gly-L-Lys and C16-Gly-D-Lys were 31 ± 3 ʅD
and 28 ± 3 ʅD (Table 1).  As such, all compounds had similar 
CACs, and as expected, the enantiomers behaved identically 
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(within error).  We also used isothermal calorimetry (ITC) to 
determine CACs via a demicellisation experiment, diluting a 
concentrated SAMul ligand solution (Tris HCl 10 mM; NaCl 150 
mM).  Once again, all compounds exhibited similar CACs (Table 
1).  These values are slightly different to those determined by 
Nile Red assay, but that is to be expected as the experimental 
conditions are somewhat different (and in the case of ITC 
matched to the polyanion binding experiments, see below). 
Table 1.  Characterisation of C16-L-Lys, C16-D-Lys, C16-Gly-L-Lys and C16-Gly-D-Lys.  
Extracted CD data (Omax and ellipticity), critical aggregation concentrations (CACs) from 
Nile Red (NR) assay (10 mM PBS, 45ºC) and ITC demicellisation experiments (10 mM 
Tris/HCl, 150 mM NaCl), DLS data (diameter and zeta potential, 10 mM Tris/HCl, 150 
mM NaCl) . 
 CD 
Omax / nm 
>T/ mdeg@ 
NR 
CAC
  
/ PM 
ITC 
CAC 
/ PM 
DLS 
Diameter 
/ nm 
DLS 
Zeta Pot 
 / mV 
C16-L-Lys 218.5 
[+5.1] 
33 ± 3 45 6.2 ± 1.7 +45.2 ± 1.6 
C16-D-Lys 218.5  
[-5.1] 
29 ± 4 48 6.3 ± 1.7 +39.2 ± 1.6 
C16-Gly- 
L-Lys 
230  
[+1.3] 
31 ± 3 49 120 ± 57 +40.1 ± 2.2 
C16-Gly-
D-Lys 
230 
 [-1.3] 
28 ± 3 47 83 ± 50 +47.1 ± 1.4 
 
 Transmission electron microscopy (TEM) was used to 
visualise the self-assembled morphologies formed on drying 
aqueous solutions.  All four compounds aggregated into similar 
micellar assemblies, with approximate diameters of ca. 8 nm 
(Fig. 3 and ESI).  Dynamic light scattering (DLS) was used to 
further characterise these self-assembled nanostructures in 
solution (Table 1). Both C16-L-Lys and C16-D-Lys formed 
aggregates ca. 6.3 nm in diameter, assigned as spherical 
micelles. Perhaps surprisingly, however, C16-Gly-L-Lys and C16-
Gly-D-Lys appeared to form larger solution-phase assemblies 
with diameters of ca. 120 nm and ca. 83 nm respectively, and 
large size distributions.  Clearly C16-Gly-L-Lys and C16-Gly-D-Lys 
are more prone than C16-L-Lys and C16-D-Lys to further 
aggregation, which must stem from the molecular-level 
insertion of the glycine spacer.  However, DLS was performed 
at elevated concentrations (0.5 mg ml
-1
, 1 mM) which can 
impact on self-assembled morphology.  We therefore also 
performed DLS at lower concentrations (down to 100 PM) to 
better reflect assay conditions, and found much greater 
contribution from smaller nanostructures (see ESI). 
 The zeta potentials of C16-L-Lys, C16-D-Lys, C16-Gly-L-Lys and 
C16-Gly-D-Lys were all similar and positive, reflecting 
protonation of lysine at physiological pH.  As such, all systems 
formed self-assembled cationic nanostructures, expected to 
bind polyanionic heparin or DNA  ? the enantiomeric pairs 
existing as charge-dense identical (mirror-image) aggregates.  
 The DNA binding ability of C16-L-Lys and C16-D-Lys was 
initially quantified by displacement of ethidium bromide 
(EthBr) from its complex with DNA monitored by fluorescence 
spectroscopy in HEPES buffer (Fig. 2).
17
  The CE50 value is the 
charge excess required for 50% displacement of EthBr, and 
EC50 is the concentration of binder at the same point (Table 2).  
The EC50 values are below the CACs of these ligands  ? it is well-
known that polyanion binding can assist cationic lipid assembly 
by limiting electrostatic repulsion at the charged SAMul 
surface.
18
  C16-L-Lys and C16-D-Lys had identical binding profiles 
(Fig. 2A) and identical CE50 values (Table 2), suggesting these 
enantiomeric self-assemblies bind DNA in identical ways  ? i.e., 
self-assembled nanoscale chirality has no significant impact on 
the molecular recognition interface.  Conversely, the EthBr 
displacement assay indicated that the DNA binding ability of 
C16-Gly-L-Lys and C16-Gly-D-Lys was significantly different (Fig. 
2C), with the former having a CE50 of 3.8 ± 0.7 but the latter 
having a CE50 of 1.5 ± 0.1, indicating much better binding 
(Table 2).  Clearly DNA has a significant preference between 
these enantiomeric assemblies.  This would suggest that on 
introducing the glycine spacer, the lysine ligands are better 
able to express their chirality at the nanoscale binding 
interface, and as such, the molecular structure of each ligand 
matters, rather than the overall charge density of the SAMul 
nanostructure being the only factor controlling binding. 
Figure 2.  Graphs from competition assays. Top: C16-L-Lys (blue) and C16-D-Lys 
(red) with (A) DNA and (B) heparin. Bottom: C16-Gly-L-Lys (blue) and C16-Gly-D-Lys 
(red) with (C) DNA and (D) heparin.  EthBr assays have [DNA] = 4 PM (per base) 
[EthBr] = 5.07 PM, in HEPES (2 mM), EDTA (0.05 mM) and NaCl (150 mM).  MalB 
assays have [heparin] = 27 PM (per disaccharide) [MalB] = 25 PM, in Tris/HCl (10 
mM) and NaCl (150 mM) 
Table 2. DNA and heparin binding data for C16-L-Lys, C16-D-Lys, C16-Gly-L-Lys and C16-D-
Lys extracted from competition assays with EthBr and MalB respectively. EthBr assays 
have [DNA] = 4 PM (per base) [EthBr] = 5.07 PM, in HEPES (2 mM), EDTA (0.05 mM) 
and NaCl (150 mM).  MalB assays have [heparin] = 27 PM (per disaccharide) [MalB] = 
25 PM, in Tris/HCl (10 mM) and NaCl (150 mM).   
 DNA Heparin 
 CE50 EC50 / PM CE50 EC50 / PM 
C16-L-Lys 1.6 ± 0.2 3.2 ± 0.4 1.8 ± 0.1 100 ± 3 
C16-D-Lys 1.7 ± 0.1 3.4 ± 0.2 1.8 ± 0.1 100 ± 3 
C16-Gly-L-Lys 3.8 ± 0.7 7.6 ± 1.3 3.3 ± 0.3 180 ± 17 
C16-Gly-D-Lys 1.5 ± 0.1 3.1 ± 0.2 2.3 ± 0.1 122 ± 2 
 
Heparin binding was quantified using a Mallard Blue (MalB) 
competition assay in which the displacement of MalB from its 
complex with heparin, is monitored by UV-vis spectroscopy.
19
  
The sigmoidal lineshape (Fig. 2) suggests that no binding takes 
place until the concentration of ligand exceeds a critical 
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concentration  ? as such, self-assembly is a pre-requisite for 
heparin binding.  The CE50 values for C16-L-Lys and C16-D-Lys 
were identical (Table 2), indicating the chiral information at 
the nanoscale surface is not expressed in binding heparin.  
However, as for DNA binding, C16-Gly-L-Lys and C16-Gly-D-Lys 
had different perfomances (Fig. 2) with CE50 values of 1.7 ± 0.2 
and 1.1 ± 0.1, respectively (Table 2).  Chiral discrimination at 
the nanoscale binding interface has clearly, been switched on 
by the presence of the glycine spacer unit. As for DNA binding, 
C16-Gly-D-Lys binds heparin significantly more effectively than 
enantiomeric C16-Gly-L-Lys. 
Figure 3.  TEM images of self-assembled nanostructures formed by C16-L-Lys.  
Images are taken in the absence of polyanion (top, scale bar = 50 nm); in the 
presence of heparin (middle, scale bar = 100 nm); in the presence of DNA (scale 
bar = 100 nm). All scale bars = 100 nm. 
 We were concerned that binding to polyanions may 
significantly disrupt the nanoscale self-assemblies, leading to 
structural reorganisation.  We therefore used TEM to image 
the SAMul nanostructures in the presence of DNA and heparin. 
In all cases, and for both families of ligand, self-assembled 
micellar objects appeared to remain intact and co-assemble 
with the polyanionic components into clustered hierarchical 
structured nano-assemblies (Fig. 3 and ESI).  This hierarchical 
assembly is a result of close packing between polycationic 
micellar spheres and polyanionic chains. dŚĞƉƌĞƐĞŶĐĞŽĨ  ?ƵŶ-
bound ? ŵŝĐĞůůĞƐ ŝŶthe TEM images arises from excess binder 
present in the samples. This imaging demonstrates that 
micellar stability is high and that self-assembly is not adversely 
affected by the presence of highly interactive polyanions. 
 Given the significant enantioselective binding differences 
induced by the introduction of a glycine spacer unit, we 
employed ITC titration methods to confirm these results and 
provide greater insight  ? detailed methodology is presented in 
the ESI  ? the SAMul systems were maintained well above their 
CAC throughout the titration in an attempt to avoid any 
thermodynamic contribution associated with de-micellisation.  
Binding isotherms are shown in Figure 4 and thermodynamic 
parameters are in Table 3.  Overall, heparin is bound more 
strongly than DNA  ? primarily driven by the larger entropic 
term.  In agreement with the EthBr/MalB displacement assays, 
the ITC results confirm that for C16-L-Lys and C16-D-Lys the self-
assembled nanoscale chirality has no significant impact on the 
molecular recognition interface (Figs. 4A and B).  Further, and 
once again in agreement with the competition assays, ITC 
indicated significant polyanion binding differences between 
C16-Gly-L-Lys and C16-Gly-D-Lys (Figs. 4C and D).  Indeed, DNA 
displays a very clear preference for C16-Gly-D-Lys over C16-Gly-
L-Lys, with 'Gbind values of -28.1 kJ mol-1 and -25.5 kJ mol-1, 
respectively (''Gbind = 2.6 kJ mol-1).  Furthermore, heparin 
binds somewhat better to C16-Gly-D-Lys with 'Gbind of -29.4 kJ 
mol
-1
 than the L enantiomer with 'Gbind of -28.5 kJ mol-1 
(''Gbind = 0.9 kJ mol-1). 
Figure 4.  ITC traces. Top: C16-L-Lys (blue) and C16-D-Lys (red) with (A) DNA and 
(B) heparin (insert is measured heat power versus time elapsed during titration 
with C16-D-Lys as an example). Bottom: C16-Gly-L-Lys (blue) and C16-Gly-D-Lys 
(red) with (A) DNA (insert is measured heat power versus time elapsed during 
titration with C16-Gly-D-Lys as an example) and (B) heparin. 
 Polyanion binding in these SAMul systems is exothermic, as 
would be expected for ion-ion interactions.  The 'Hbind values 
for heparin binding are -13.7 and -12.3 kJ mol
-1
 for C16-Gly-D-
Lys and C16-Gly-L-Lys respectively (''Hbind = 1.4 kJ mol-1)., and 
for DNA binding they are -15.7 and -11.6 kJ mol
-1
 respectively 
(''Hbind = 4.1 kJ mol-1).  The entropy values are positive, which 
suggests a degree of disorder induced by binding as solvent 
and ions are released from the nanoscale binding interface.  
Entropic differences between enantiomers are somewhat 
smaller.  For heparin binding, T'Sbind values are +15.7 and 
+16.2 kJ mol
-1
 for the D- and L- systems respectively ('T'Sbind = 
-0.5 kJ mol
-1
), while for DNA binding, these values are +12.5 
and +13.9 kJ mol
-1 
respectively ('T'Sbind = -1.4 kJ mol-1).  As 
such, it is clear that the enhanced binding of C16-Gly-D-Lys with 
DNA and also, to a lesser extent with heparin, is primarily of 
COMMUNICATION Journal Name 
4 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
enthalpic origin.  This enhanced enthalpic effect is slightly 
offset by a smaller entropic gain for C16-Gly-D-Lys, but enthalpy 
dominates.  As such, we suggest that specific ligand-polyanion 
interactions are optimised on the surface of the C16-Gly-D-Lys 
in comparison with C16-Gly-L-Lys.  The lower enantioselectivity 
of heparin towards these SAMul systems compared with DNA 
may result from the more polydisperse nature of heparin 
leading to a less well-defined distribution of anionic binding 
sites.  In DNA, the structure of the polymer is more well-
defined, with anionic sites evenly and repetitively spaced 
down the helical backbone, hence potentially benefitting more 
from an appropriately structured binding partner.  
Table 3. DNA and heparin binding data for C16-L-Lys, C16-D-Lys, C16-Gly-L-Lys and C16-D-
Lys extracted from ITC (10 mM Tris/HCl, 150 mM NaCl).  All data are in kJmol
-1
. 
 DNA Heparin 
 'Gbind 'Hbind -T'Sbind 'Gbind 'Hbind -T'Sbind 
C16-L-Lys -27.3 -14.0 -13.3 -31.1 -14.6 -16.5 
C16-D-Lys -27.7 -15.5 -12.1 -30.8 -14.2 -16.6 
C16-Gly-L-Lys -25.5 -11.6 -13.9 -28.5 -12.3 -16.2 
C16-Gly-D-Lys -28.1 -15.7 -12.5 -29.4 -13.7 -15.7 
  
 There are several potential reasons why the glycine spacer 
switches on enantioselective binding in this system.  Most 
likely, as evidenced by DLS, is that the glycine spacer modifies 
the polarity and shape of the amphiphile and hence changes 
the self-assembled morphology, enabling the optimisation of 
the binding interface and greater selectivity.  We can rule out 
any impact of charge density, as all systems have very similar 
zeta potentials.  However, it is also possible that the additional 
glycine amide hydrogen bonding site may enable more specific 
interaction with the binding partner.  Determining the relative 
importance of these different factors is the focus of a larger 
ongoing structure-activity relationship study.  Clearly, 
however, polyanion binding is sensitive to the way ligands are 
displayed on the surface of SAMul nanostructures.  
Understanding such effects is important in predicting and 
understanding the selectivity of binding processes at self-
assembled bio-surfaces, such as cell membranes, as well as in 
optimising binding to nanoscale biological targets such as 
these clinically important polyanions. 
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Graphical Abstract 
We investigate structure-activity effect relationships at the nanoscale chiral molecular recognition interface 
between enantiomeric self-assembled multivalent (SAMul) systems and biological polyanions, heparin and DNA. 
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